TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

COVALFINDER

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: VerbalEscritório: US

Snapshot rápido

COVALFINDER

ST13

US500000097053441

Classe

9, 42

Pedido

97053441

Registro

7191864

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

34

Atualização mais recente

17/10/2023

Classificação

Registrada

Tipo de marca

Verbal

Classes Nice

9, 42

Data de depósito

30/09/2021

Data de registro

17/10/2023

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

17/10/2023

Última transação

17/10/2023

Escritório responsável

United States Patent and Trademark Office

Código da situação

700

Cadastro oficial

Principal Register

Código do desenho

4

Tipo de titular

16

Localização do titular

Madrid, ES

Examinador

KELLEY, EVELYN

Unidade examinadora

N90

Localização atual

PUBLICATION AND ISSUE SECTION

Titulares e representantes

Titulares

E. S. (pessoa física)

Representantes

Tristan A. Fuierer Casimir Jones, S.C.

Classificação técnica

Classes Nice

Classe 9Classe 42

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 9

Recorded software for use in data analysis, data generation or database management in the pharmaceutical and biotechnology industries; Recorded science software for use in data analysis, data generation or database management in the pharmaceutical and biotechnology industries; Recorded bioinformatics software for use in data analysis, data generation or database management in the pharmaceutical and biotechnology industries; Recorded computer software for use in data analysis, data generation or database management in the pharmaceutical and biotechnology industries; Embedded software for use in data analysis, data generation or database management in the pharmaceutical and biotechnology industries; Recorded computer software packages for use in data analysis, data generation or database management in the pharmaceutical and biotechnology industries; All the aforesaid software being limited to the pharmaceutical and biotechnology industries; None of the foregoing including and all of the foregoing excluding software and products relating to the commercialization of new pharmaceutical drugs, biopharmaceuticals, and therapeutics for the treatment of disease

Classe 42

Science and technology services, namely, research and design in the field of pharmaceutical and biotechnology industries; Technical research in the field of pharmaceutical and biotechnology studies; Scientific services and design relating thereto; Technological consulting services and engineering design relating thereto; Scientific research; Industrial analysis and research services in the field of pharmaceuticals and biotechnology; Software design and development; Design and development of computer hardware; Mathematical research services; Computer software creation; Installation of computer software; Computer software research; Software development; Computer programming services for others in the field of software configuration management; Computer software design; Updating of computer software; Software engineering; All the aforesaid services being limited to the pharmaceutical and biotechnology industries; None of the foregoing including and all of the foregoing excluding services relating to the commercialization of new pharmaceutical drugs, biopharmaceuticals, and therapeutics for the treatment of disease

Publicações

Histórico de despachos e eventos da marca no USPTO.

34 publicações encontradas

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

17/10/2023

R.PR

REGISTERED-PRINCIPAL REGISTER

17/10/2023

ETOP

EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED

10/09/2023

CHPB

POST PUBLICATION AMENDMENT - ENTERED

29/08/2023

APET

ASSIGNED TO PETITION STAFF

28/08/2023

EPPA

TEAS POST PUBLICATION AMENDMENT RECEIVED

10/08/2023

ETOF

EXTENSION OF TIME TO OPPOSE RECEIVED

01/06/2023

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

02/05/2023

PUBO

PUBLISHED FOR OPPOSITION

02/05/2023

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

12/04/2023

FIXD

ELECTRONIC RECORD REVIEW COMPLETE

27/03/2023

ERRR

ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED

24/03/2023

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

22/03/2023

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

15/11/2022

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

15/11/2022

ERFR

TEAS REQUEST FOR RECONSIDERATION RECEIVED

15/11/2022

GNFN

NOTIFICATION OF FINAL REFUSAL EMAILED

05/11/2022

GNFR

FINAL REFUSAL E-MAILED

05/11/2022

CNFR

FINAL REFUSAL WRITTEN

05/11/2022

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

21/10/2022

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

21/10/2022

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

21/10/2022

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

18/10/2022

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

18/10/2022

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

18/10/2022

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

07/07/2022

GNRT

NON-FINAL ACTION E-MAILED

07/07/2022

CNRT

NON-FINAL ACTION WRITTEN

07/07/2022

DOCK

ASSIGNED TO EXAMINER

30/06/2022

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

15/02/2022

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

15/02/2022

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

15/02/2022

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

28/10/2021

NWAP

NEW APPLICATION ENTERED

04/10/2021

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace COVALFINDER ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.